| Identification | Back Directory | [Name]
Dibrompropamidine | [CAS]
496-00-4 | [Synonyms]
Dibrompropamidine
4,4'-(Trimethylenedioxy)bis(3-bromobenzamidine)
4,4'-(Trimethylenebisoxy)bis(3-bromobenzamidine)
4,4'-[1,3-Propanediylbisoxy]bis(3-bromobenzamidine)
4,4'-[1,3-Propanediylbis(oxy)]bis(3-bromobenzamidine)
Benzenecarboximidamide, 4,4'-[1,3-propanediylbis(oxy)]bis[3-bromo- | [Molecular Formula]
C17H18Br2N4O2 | [MDL Number]
MFCD00866767 | [MOL File]
496-00-4.mol | [Molecular Weight]
470.16 |
| Hazard Information | Back Directory | [Originator]
Dibrompropamidine,Aventis Pharma AS | [Definition]
ChEBI: Dibrompropamidine is an aromatic ether. | [Manufacturing Process]
2,2’-Dibromo-4,4’-dicyano-α,γ-diphenoxypropane (3.0 g) and anhydrous
ethanol (3.0 ml) were dissolved in anhydrous chloroform (40 ml). The solution
was saturated at 0°C with dry hydrogen chloride and set aside for 7 day. The
iminoether hydrochloride which crystallised out, was filtered off and washed
with light petroleum. The solid was added to 12% ammoniacal ethanol (47
c.c.) and the mixture was heated at 60°C for 6 hours. Solution was obtained
after 3 hours and the amidine hydrochloride began to cryistallise. The mixture
was ice-cooled, and the white crystalline solid was filtered off, washed with 2
N hydrochloric acid, and recrystallised twice from 0.5 N hydrochloric acid.
2,2'-Dibromo-4,4'-diamidino-α,γ-diphenoxypropane dihydrochloride (2.1 g)
[another name: 4,4'-(Trimethylenedioxy)bis(3-bromobenzamidine)] separated
as white prisme. Melting point 309°C. (decomp.).
Berg S.S., GB Patent No. 598,911; March 22, 1945; Assigned to May and
Bakker Limited, a British Co., Dagenham, Essecs. | [Therapeutic Function]
Antiprotozoal |
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|